New Haven, CONNECTICUT2 Active Studies

Chronic Kidney Disease Clinical Trials in New Haven, CONNECTICUT

Find 2 actively recruiting chronic kidney disease clinical trials in New Haven, CONNECTICUT. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
206
Enrolling

Recruiting Chronic Kidney Disease Studies in New Haven

About Chronic Kidney Disease Clinical Trials in New Haven

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 2 chronic kidney disease clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 206 participants. Research is being sponsored by Humacyte, Inc., Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in New Haven — FAQ

Are there chronic kidney disease clinical trials in New Haven?

Yes, there are 2 chronic kidney disease clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated March 2, 2026 from ClinicalTrials.gov